Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 9/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.47 |
| ▸ | IDO1 | P14902 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.46 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.45 |
| ▸ | LAP3 | P28838 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4989084 | 1.00 | LTA4H (0.48) | LTA4HALDH1A1KMT2AALOX15BLM | |
| Hydrochloric Acid SCHEMBL7393352 | 0.98 | LTA4H (0.47) | LTA4HALDH1A1KMT2AALOX15BLM | |
| Hydrochloric Acid SCHEMBL9188911 | 0.98 | LTA4H (0.47) | LTA4HALDH1A1KMT2AALOX15BLM | |
| Trifluoroacetic Acid SCHEMBL28255326 | 0.92 | LTA4H (0.43) | LTA4HALDH1A1KMT2AALOX15BLM | |
| SCHEMBL561573 | 0.89 | LTA4H (0.56) | LTA4HALDH1A1KMT2AIDO1MAPK1 | |
| SCHEMBL28192478 | 0.89 | LTA4H (0.56) | LTA4HALDH1A1KMT2AIDO1MAPK1 | |
| SCHEMBL124387 | 0.89 | LTA4H (0.56) | LTA4HALDH1A1KMT2AIDO1MAPK1 | |
| SCHEMBL21232385 | 0.89 | LTA4H (0.56) | LTA4HALDH1A1KMT2AIDO1MAPK1 | |
| SCHEMBL6672089 | 0.88 | LTA4H (0.44) | LTA4HALDH1A1KMT2AALOX15BLM | |
| Hydrochloric Acid SCHEMBL15266392 | 0.87 | LTA4H (0.54) | LTA4HALDH1A1KMT2AIDO1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119751538-A | Medicine for removing fat or fat pad and application | 西安莱格瑞生物科技有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-117815245-A | Medicine for removing fat or fat pad and application | 西安莱格瑞生物科技有限公司 | 2024-04-05 | — | — | CN | claimed |
| US-20240065990-A1 | METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID | BELLUS HEALTH INC (CA) | 2024-02-29 | — | — | US | claimed |
| EP-3851447-B1 | METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID | BELLUS HEALTH INC (CA) | 2023-09-06 | — | — | EP | claimed |
| CN-113914124-A | Modified nano-cellulose and application thereof in preparation of base paper | 华邦特西诺采新材料股份有限公司 | 2022-01-11 | — | — | CN | claimed |
| EP-3851447-A1 | METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID | BHI Limited Partnership (CA) | 2021-07-21 | — | — | EP | claimed |
| CN-102241674-B | Synthesis method and antitumor activity evaluation of 1,1-dimethyl-beta-carboline-3-formacyl amino acid benzyl ester | UNIV CAPITAL MEDICAL | 2012-09-12 | — | — | CN | claimed |
| CN-102250202-A | 1-paranitrophenyl-beta-carboline-3-formyl amine acid carbamates and synthesis method and use thereof | UNIV CAPITAL MEDICAL | 2011-11-23 | — | — | CN | claimed |
| CN-102241674-A | Synthesis method and antitumor activity evaluation of 1,1-dimethyl-beta-carboline-3-formacyl amino acid benzyl ester | UNIV CAPITAL MEDICAL | 2011-11-16 | — | — | CN | claimed |
| CN-101497615-B | Substituted purine, preparation and use in medicine | ZHEJIANG MED XINCHANG PHARM | 2010-12-15 | — | — | CN | claimed |
| CN-101906102-A | Beta-carboline alkaloid derivative, preparation method and application thereof | UNIV CAPITAL MEDICAL | 2010-12-08 | — | — | CN | claimed |
| CN-101597289-A | 2-tryptophyl-beta-tetrahydro carboline-3-formyol amino-acid benzyl ester and its production and application | UNIV CAPITAL MEDICAL (CN) | 2009-12-09 | — | — | CN | claimed |
| CN-101597290-A | β-Ka Lin-3-formyl tryptophyl amino-acid benzyl ester and its production and application | UNIV CAPITAL MEDICAL (CN) | 2009-12-09 | — | — | CN | claimed |
| CN-101497615-A | Substituted purine, preparation and use in medicine | XINCHANG PHARMACEUTICAL FACTORY ZHEJIANG MEDICINE CO LTD (CN) | 2009-08-05 | — | — | CN | claimed |
| US-20080146642-A1 | Propanesulfonic acid amino acid prodrugs that can deliver 3-amino-1-propanesulfonic acid (3APS) by minimizing metabolism associated with that drug, particularly compounds that block or protect amino group of 3APS such that it avoids metabolism by transaminases or monoamine oxidase; Alzheimer's disease | BELLUS HEALTH INC. (CA) | 2008-06-19 | — | — | US | claimed |
| US-20250304603-A1 | OXABOROLE ESTERS AND USES THEREOF | ANACOR PHARMACEUTICALS INC (US) | 2025-10-02 | — | — | US | disclosed |
| CN-120058839-A | 2-Asn-tetrahydroisoquinoline-3S-formyl-Leu, and preparation and application thereof | 首都医科大学 | 2025-05-30 | — | — | CN | disclosed |
| US-4146641-A | ANGIOTENSIN CONVERTING ENZYME INHIBITORS | E. R. SQUIBB & SONS, INC. (US) | 1979-03-27 | — | — | US | disclosed |
| US-4146639-A | ANGIOTENSIN CONVERTING ENZYME INHIBITORS | E. R. SQUIBB & SONS, INC. (US) | 1979-03-27 | — | — | US | disclosed |
| US-4105789-A | Carboxyalkylacylamino acids | E. R. SQUIBB & SONS, INC. (US) | 1978-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240065990-A1 | METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID | APP, PSEN1, PSEN2 | LTA4H 982/4885ALDH1A1 888/4885KMT2A 3091/4885 |
| US-20250304603-A1 | OXABOROLE ESTERS AND USES THEREOF | OXA1L, HSD17B12, OXER1 | LTA4H 234/4885ALDH1A1 585/4885KMT2A 3433/4885 |
| US-20080146642-A1 | Propanesulfonic acid amino acid prodrugs that can deliver 3-amino-1-propanesulfonic acid (3APS) by minimizing metabolism associated with that drug, particularly compounds that block or protect amino group of 3APS such that it avoids metabolism by transaminases or monoamine oxidase; Alzheimer's disease | DNPEP, DAO, APP | LTA4H 1290/4885ALDH1A1 103/4885KMT2A 2014/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.